Showing results (41-50 of 51) with videos related to
Sort By:
Pageof 6
Proceedings of the National Academy of Sciences of the United States of America|January 28, 2009
Dysregulation of CalDAG-GEFI and CalDAG-GEFII predicts the severity of motor side-effects induced by anti-parkinsonian therapyJill R Crittenden, Ippolita Cantuti-Castelvetri, Esen Saka, et al.Neurological Research|August 24, 2017
Epigenetic approach to early-onset Parkinson's disease: low methylation status of SNCA and PARK2 promoter regionsIsil Ezgi Eryilmaz, Gulsah Cecener, Sevda Erer, et al.Plos One|November 19, 2010
Levodopa-induced dyskinesia is associated with increased thyrotropin releasing hormone in the dorsal striatum of hemi-parkinsonian ratsIppolita Cantuti-Castelvetri, Ledia F Hernandez, Christine E Keller-McGandy, et al.Clinical Neurology and Neurosurgery|October 11, 2020
Contribution of functional dopamine D2 and D3 receptor variants to motor and non-motor symptoms of early onset Parkinson's diseaseIsil Ezgi Eryilmaz, Sevda Erer, Mehmet Zarifoglu, et al.Parkinsonism & Related Disorders|March 29, 2017
The p.Thr11Met mutation in c19orf12 is frequent among adult Turkish patients with MPANSimone Olgiati, Okan Doğu, Zeynep Tufekcioglu, et al.Biomarkers in Medicine|August 25, 2012
Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an updateMarta del Campo, Brit Mollenhauer, Antonio Bertolotto, et al.Movement Disorders Clinical Practice|October 27, 2018
Turkish Standardization of Movement Disorders Society Unified Parkinson's Disease Rating Scale and Unified Dyskinesia Rating ScaleMuhittin C Akbostanci, Ece Bayram, Volkan Yilmaz, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 26, 2017
Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementiaAnja Hviid Simonsen, Sanna-Kaisa Herukka, Niels Andreasen, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 26, 2017
Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairmentSanna-Kaisa Herukka, Anja Hviid Simonsen, Niels Andreasen, et al.Journal of Alzheimer'S Disease : JAD|January 7, 2017
Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular VolumesLinda J C van Waalwijk van Doorn, Juan D Gispert, H Bea Kuiperij, et al.Pageof 6